Old Web
English
Sign In
Acemap
>
Paper
>
Title Page. Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial
Title Page. Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial
2010
Ronney Shantouf
Matthew J. Budoff
Naser Ahmadi
Arshia Ghaffari
Ferdinand Flores
Ambarish Gopal
Nazanin Noori
Jennie Jing
Csaba P. Kovesdy
Kamyar Kalantar-Zadeh
Matthew R. Weir
Zohra Tumur
Hidehisa Shimizu
Atsushi Enomoto
Hitoshi Miyazaki
Toshimitsu Niwa
Dick de Zeeuw
Richard J. Glassock
Joyce R. Byers
Gregory B. Russell
Robert J. Stratta
Anthony J. Bleyer
Yonghong Shi
Chunyang Du
Yanling Zhang
Yunzhuo Ren
Jun Hao
Song Zhao
Fang Yao
HuiJun Duan
Meyeon Park
Steven G. Coca
Sagar U. Nigwekar
Amit X. Garg
Susan Garwood
Chirag R. Parikh
Marshall M. Joffe
Chi-Yuan Hsu
Harold I. Feldman
Matthew R. Weir
J. R. Landis
L. Lee Hamm
Utpal Sen
Charu Munjal
Natia Qipshidze
Oluwasegun A. Abe
Riyad Gargoum
Suresh C. Tyagi
Barry I. Freedman
Zak K. Shihabi
Lilian Andries
Cesar Y. Cardona
Todd P. Peacock
Hiddo J. Lambers-Heerspink
George L. Bakris
Claire E. Hills
Nigel J. Brunskill
Paul E. Squires
Seyed Mohammadmehdi Hosseini-Moghaddam
Afagh Zarei
Seyed Moayed Alavian
Mehdi Mansouri
Keywords:
Clinical trial
Endocrinology
Microalbuminuria
Physical therapy
Internal medicine
Title page
Pediatrics
Medicine
Alternative medicine
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]